Form 4: Progyny Director Beth C. Seidenberg Reports Stock Transactions

Director Beth C. Seidenberg reports acquisition of restricted stock units and stock options, along with adjustments to direct and indirect holdings of Progyny, Inc. stock.

Summary

• On May 23, 2024, Beth C. Seidenberg, a director of Progyny, Inc., reported transactions involving the company's stock.
• Seidenberg acquired 7,206 shares of common stock underlying restricted stock units (RSUs) at a price of $0, which will vest on May 23, 2025.
• She also acquired 26,926 stock options with an exercise price of $27.15, which will vest on May 23, 2025, and expire on May 22, 2034.
• Following these transactions, Seidenberg directly owns 43,416 shares of common stock.
• Seidenberg also has indirect beneficial ownership of 5,074,615 shares held by KPCB XIII and 227,906 shares held by The Seidenberg/Vogel Revocable Trust.
• She disclaims beneficial ownership of the shares held by KPCB XIII except to the extent of her pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock transactions. The acquisition of RSUs and options could be interpreted as a slightly positive signal.

Positives

• The acquisition of RSUs and stock options by a director could be seen as a positive sign of confidence in the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track potential shifts in ownership and sentiment.

Stakeholder Impact

• The reported transactions provide shareholders with insights into the director's investment activities and alignment with the company's performance.

Key Dates